Treatment of irritant contact dermatitis in healthcare settings during the COVID19 pandemic: The emollient Dermol 500 exhibits virucidal activity against influenza A virus and SARS-CoV-2

Christine T. Styles, Michael Vanden Oever, Jonathan Brown, Sweta Rai, Sarah Walsh, Finola M. Ryan, Wendy S. Barclay, Rachel S. Edgar
doi: https://doi.org/10.1101/2021.02.12.21251419

Data Availability

Data is available on request.

Back to top
Posted March 11, 2021.
Download PDF
Data/Code
Email
Treatment of irritant contact dermatitis in healthcare settings during the COVID19 pandemic: The emollient Dermol 500 exhibits virucidal activity against influenza A virus and SARS-CoV-2
Christine T. Styles, Michael Vanden Oever, Jonathan Brown, Sweta Rai, Sarah Walsh, Finola M. Ryan, Wendy S. Barclay, Rachel S. Edgar
medRxiv 2021.02.12.21251419; doi: https://doi.org/10.1101/2021.02.12.21251419
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area